Contract awardedBlood collection, apheresis and component processing

MNC and CMNC software from Terumo supports gene therapy apheresis at BWC

Birmingham Women's and Children's NHS Foundation Trust bought MNC and CMNC software from Terumo UK Limited for use in gene therapy apheresis.

The trust took licensing and support for the software straight from Terumo, the manufacturer, without a competition. The £19,560 contract was set to run for one month, from May to June 2026.

What
Blood collection, apheresis and component processing
Value
£19,560
How it was bought
Below threshold - without competition
Dates and next
May 2026 to Jun 2026

How it was bought

1 official notice
  1. 18 May 2026Contract starts
  2. 18 Jun 2026Contract ends
  3. 21 Jul 2026Award noticeFind a Tender

How it compares

With every blood collection, apheresis and component processing award since 2021

Half of awards fall between £82,958 and £1.11mMedian £302,667

Awards
88
Firms that won them
27
Median award
£302,667
of 79 with a value
This award
Smaller than 95%
of them
Typical length
3 years
In West Midlands
4 awards

Terumo UK Limited ranks 6th of 27 firms for blood collection, apheresis and component processing awards since 2021.

RankFirmAwardsValue
1Locked22£21.7m
2Locked8£28.8m
3Locked7£99.7m
3Locked7£5.05m
5Locked4£195,116
6Locked3£501,120
6Terumo UK Limited Won this one3£33,019
See who wins this work

Figures to 21 November 2026

Blood collection, apheresis and component processing at other buyers

Birmingham Women's and Children's NHS Foundation Trust has awarded 312 contracts since 2021.

See Birmingham Women's and Children's NHS Foundation Trust's page
  • Terumo UK Limited has won 14 public contracts since 2021.